Items Tagged ‘myelofibrosis’

December 15, 2017

Mayo Clinic in the News Weekly Highlights for December 15, 2017

By Karl Oestreich

      New York Times, Sleep vs. Exercise? by Karen Weintraub — Desiree Ahrens, a certified health and wellness coach at the Mayo Clinic in Rochester, Minn., said that for the time-starved, there are ways to sneak exercise into the day without heading to the gym or a formal exercise class. Running up the […]

View full entry

Tags: addiction, aging, alzheimer's disease, anxiety, Balloon Brigade, Biofourmis, brain surgery, Breast Cancer, burnout, Children's Memorial Day, concussion, Desiree Ahrens


February 19, 2016

Mayo Clinic in the News Weekly Highlights

By Karl Oestreich

Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Heather Privett  with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Editor, Karl Oestreich;  Assistant Editor: Carmen Zwicker   New York Times Ask Well: Are Pomegranates Good For You? […]

View full entry

Tags: ABC 15 Arizona, ABC News, ABC15's Rally for Red, Advances in Radiation Oncology Journal, Alzforum, Arizona Horizon (PBS), Arizona Republic, Augustine Record, basal carcinoma, Becker’s Hospital Review, bioresorbable vascular scaffolds (BVS), Bloomberg News


June 18, 2015

Mayo Clinic In The News Weekly Highlights

By Karl Oestreich

Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Laura Wuotila with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Editor, Karl Oestreich; Assistant Editor, Carmen Zwicker   MSNBC Morning Joe Mayo clinic offers patient care to Walmart […]

View full entry

Tags: "Viagra for women, 3D printing in health care, AARP Espanol, ABC 15 Arizona, ABC Action Philadelphia, ABC6 On Your Side Ohio, Alianza Tex, allergy relief, Alnylam's RNAi therapy, amyloid disease, anti-seizure med, Argus Leader Sioux Falls


June 12, 2015

Mayo Clinic in the News Weekly Highlights

By Karl Oestreich

Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Laura Wuotila with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Editor, Karl Oestreich; Assistant Editor, Carmen Zwicker   Boston Globe In the future, treatments tailored to […]

View full entry

Tags: Abu Dhabi firm, ALS disease, anesthesia in young children, Annual Forbes 400 Summit On Philanthropy, Arizona Daily Sun, Arizona Horizon, Arizona Public Media, Arizona Republic, artist Kurt Perschke, Assisted Reproductive Technology, ASU/Mayo Medical School, avatar mice


December 20, 2013

Mayo Clinic in the News Weekly Highlights

By Karl Oestreich

December 20, 2013 Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Emily Blahnik with this subject line: SUBSCRIBE to Mayo Clinic in the News. This is our last news summary of 2013. Please […]

View full entry

Tags: ABC News, ABC15, american heart association, American Society of Hematology, anesthesia, antibacterial soap, AP, aphasia, Arizona State University, Associated Press, ASU, bacteria


December 13, 2013

Mayo Clinic in the News Weekly Highlights

By Karl Oestreich

    December 13, 2013 Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Emily Blahnik with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Karl Oestreich, manager enterprise media […]

View full entry

Tags: ABC News, AIDS, Altru Health System, American Society of Hematology, Anastrozole, AP, Arimidex, ASH, Asperger's, Associated Press, Austin Public Schools, BBC


March 1, 2012

Ruxolitinib in Myelofibrosis: Only for Some Patients

By

The first drug ever approved for myelofibrosis, ruxolitinib (Jakafi, Incyte/Novartis), is useful only in about 25% of patients with this disorder, according to Ayalew Tefferi, MD, from the division of hematology at the Mayo Clinic Rochester, Minnesota. Even then, it might not be the best option, he added. Dr. Tefferi was speaking to Medscape Medical […]

View full entry

Tags: Ayalew Tefferi, myelofibrosis, New England Journal of Medicine, ruxolitinib


Contact Us · Privacy Policy